Categories
News Newsletter

Newsletter #16

Click to go to the ISNCT #16 Newsletter The newsletter #16 includes information about: The updates in the website and social media Prof. Andrés Kreiner interview YBNCT 2022 important news: Registration, Sponsors The 2022 OU-IAEA Joint Workshop on BNCT Report by Katsuyo Iwaga Advances in Boron Neutron Capture Therapy at the 66th IAEA General Conference […]

Categories
Interview News

Interview to Prof. Dr. Andres Kreiner

Prof. Dr. Andres Kreiner (Comisión Nacional de Energía Atómica CNEA, Buenos Aires, Argentina)Head of Department at the CNEA As usual, we invite you to meet us on our website, facebook, instagram, twitter and our youtube channel.You can also write to news@isnct.net or share your news through our contact form. We will be really happy to hear from you!

Categories
Article Biodistribution Boron Compounds Boron imaging Chemistry In-vitro Studies In-vivo Studies Year 2021

Radiolabeled cobaltabis(dicarbollide) anion graphene oxide nanocomposites for in vivo bioimaging and boron delivery

Applied Nanomaterials, 2021

Categories
Article Boron compound Chemistry In-vitro Studies Year 2022

The Mossbauer effect using Fe-57-ferrabisdicarbollide ([o-(57)FESAN](-)): a glance into the potential of a low-dose approach for glioblastoma radiotherapy

Inorganic Chemistry Frontiers, 2022

Categories
Article Boron Determination In-vitro Studies Radiobiology Year 2021

Cobaltabis(dicarbollide) ([o-COSAN]-) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma

Cancers, 2021

Categories
Article Biodistribution Boron Compounds Chemistry In-vitro Studies In-vivo Studies Year 2018

Metallacarboranes on the Road to Anticancer Therapies: Cellular Uptake, DNA Interaction, and Biological Evaluation of Cobaltabisdicarbollide [COSAN]-

Chemistry European Journal, 2018

Categories
Article Boron Compounds Boron imaging Chemistry Year 2019

Periphery Decorated and Core Initiated Neutral and Polyanionic Borane large molecules: Forthcoming and Promising properties for medicinal Applications

Current Medicinal Chemistry, 2019

Categories
Article Boron Compounds Boron Determination Chemistry In-vitro Studies Year 2020

Ruthenium carboranyl complexes with 2,2’-bipyridine derivatives for potential bimodal therapy application

RSC Advances, 2020

Categories
Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020

Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity

Cancers, 2020

Categories
Article Boron Compounds Chemistry In-vitro Studies Radiobiology Year 2020

Bimodal Therapeutic Agent against Glioblastoma, one the most Lethal Cancer

Chemistry European Journal, 2020